Abu Dhabi and Belgium establish pharma air corridor
The dedicated pharma trade lane will unite key compliant and sector-certified supply chain stakeholders and help Abu Dhabi to strengthen its capabilities as a life sciences hub
Abu Dhabi and Belgium have formed a collaboration to establish a global distribution corridor to serve the world in vaccine delivery and future life science needs.
The collaboration builds on the capabilities of Abu Dhabi’s healthcare sector as a leading life sciences hub and the efforts of the HOPE Consortium in providing vaccine solutions for the world.
This initiative, which entailed a delegation visit from Belgium to Abu Dhabi, hosted by the Department of Health - Abu Dhabi, saw the signing of two declarations of collaboration between Belgium and Abu Dhabi.
The first was between the HOPE Consortium, Abu Dhabi Airports Company, Brussels Airport Company and Pharma.Aero, and aims to unite key compliant and sector-certified supply chain stakeholders, including forwarders and ground handling agents, to establish a fully compliant origin-to-destination pharma air corridor between Abu Dhabi and Brussels Airports.
Earlier this year, a delegation from the HOPE Consortium met with pharmaceutical industry stakeholders in Brussels to showcase Abu Dhabi’s global vaccine distribution success. Thanks to its network of partners, the HOPE Consortium has handled more than 200 million doses of Covid-19 vaccines, contributing to vaccination programmes in over 40 global destinations.
According to Nathan De Valck, head of cargo at Brussels Airport, Brussels Airport is the leading hub serving the pharmaceutical and life sciences industry in Europe with more than 750 million vaccines handled at the airport, serving 60 destinations worldwide.
The second declaration of collaboration was signed by the HOPE Consortium, Pharma.Aero, Khalifa University of Science and Technology and the University of Antwerp to host the second edition of the 'Pharma Logistics Masterclass' — a course focussing on critical challenges and developments in pharma supply chains and logistics, by Khalifa University in Abu Dhabi 5–9 September 2022.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance